Axogen (LTS:0HKD) Operating Margin %: -4.61% (As of Mar. 2026)


LTS:0HKD Axogen Inc LTS:0HKD
62 GF Score
Price $44.13
GF Value $14.95
Valuation Significantly Overvalued
! 4 Warning Signs
View Full Analysis

What is Axogen Operating Margin %?

Axogen LTS:0HKD +2.13% 62 Operating Margin % is -4.61% as of Mar. 2026. GuruFocus rates LTS:0HKD with a GF Score™ of 62/100 and a GF Value™ of $14.95 (Significantly Overvalued). The stock has 4 warning signs investors should review. Among 817 Medical Devices & Instruments companies, Axogen ranks worse than 60.34% on this metric.

Operating Margin % is calculated as Operating Income divided by its Revenue. Axogen's Operating Income for the three months ended in Mar. 2026 was $-2.8 Mil. Axogen's Revenue for the three months ended in Mar. 2026 was $61.5 Mil. Therefore, Axogen's Operating Margin % for the quarter that ended in Mar. 2026 was -4.61%.

Good Sign:

Axogen Inc operating margin is expanding. Margin expansion is usually a good sign.

The historical rank and industry rank for Axogen's Operating Margin % or its related term are showing as below:

LTS:0HKD' s Operating Margin % Range Over the Past 10 Years
Min: -29.43   Med: -19.87   Max: -1.75
Current: -3.79


LTS:0HKD's Operating Margin % is ranked worse than
60.34% of 817 companies
in the Medical Devices & Instruments industry
Industry Median: 3.41 vs LTS:0HKD: -3.79

Axogen's 5-Year Average Operating Margin % Growth Rate was 37.90% per year.

Axogen's Operating Income for the three months ended in Mar. 2026 was $-2.8 Mil. Its Operating Income for the trailing twelve months (TTM) ended in Mar. 2026 was $-9.0 Mil.


Axogen  (LTS:0HKD) Operating Margin % Explanation

Just like Gross Margin %, it is important to see a company maintains its operating margin over time. Among the same industry, a company with higher operating margin is more efficient in its operation. It is also more stable during industry slowdown or recessions. Peter Lynch prefers those with higher margins than those with lower margins.


Be Aware

Operating Margin % can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).

If a company is facing competition, its Operating Margin % may decline. Often the Operating Margin % declines well before the company's Revenue or even profit decline. Therefore, Operating Margin % is a very important indicator of whether the company is facing problems.

For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokia’s Operating Margin % had already been in decline since 2002, although its Earnings per Share (Diluted) were still rising. Investors who paid attention to Operating Margin % would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).

Therefore, Operating Margin % is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.


Axogen Operating Margin % Related Terms


Axogen Operating Margin % Historical Data

* Premium members only.

The historical data trend for Axogen's Operating Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Axogen Operating Margin % Chart

Axogen Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Operating Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -19.96 -21.44 -13.50 -1.75 -3.49

Axogen Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Operating Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -3.42 2.95 3.18 -16.31 -4.61

LTS:0HKD vs ESTA, NVCR, NEOG: Operating Margin % Comparison

For the Medical Devices subindustry, Axogen's Operating Margin %, along with its competitors' market caps and Operating Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Axogen Operating Margin % vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Axogen's Operating Margin % distribution charts can be found below:

* The bar in red indicates where Axogen's Operating Margin % falls into.


LTS:0HKD
62GF Score
Axogen Inc LTS:0HKD
Operating Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Axogen Operating Margin % Calculation

Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.

Axogen's Operating Margin % for the fiscal year that ended in Dec. 2025 is calculated as

Operating Margin %=Operating Income (A: Dec. 2025 ) / Revenue (A: Dec. 2025 )
=-7.849 / 225.208
=-3.49 %

Axogen's Operating Margin % for the quarter that ended in Mar. 2026 is calculated as

Operating Margin %=Operating Income (Q: Mar. 2026 ) / Revenue (Q: Mar. 2026 )
=-2.832 / 61.457
=-4.61 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Operating Margin % →
What does a Operating Margin % of -4.61% mean?
Axogen (LTS:0HKD) has a Operating Margin % of -4.61% as of Mar. 2026. Operating margin is the ratio of total operating income to net sales. View historical data on Axogen and its competitors. According to the industry distribution chart, Axogen ranks #493 out of 817 companies in the Medical Devices & Instruments industry, placing it in the top 60.3%.
Is Axogen's Operating Margin % too high?
Axogen's current Operating Margin % is -4.61%. Based on the distribution chart, Axogen ranks #493 out of 817 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Axogen has a GF Score™ of 62/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Axogen's Operating Margin % compare to ESTA and NVCR?
According to the Medical Devices & Instruments industry distribution chart, Axogen ranks #493 out of 817 companies for Operating Margin %. This places Axogen in the lower half of its industry. The industry median Operating Margin % is 3.41. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Operating Margin % for a Medical Devices & Instruments company?
The median Operating Margin % among Medical Devices & Instruments companies is 3.41, based on 817 companies in the industry. Companies in the top quartile (top 25%) have a Operating Margin % significantly above this median, while those in the bottom quartile fall well below. However, Operating Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Operating Margin % mean?
A high Operating Margin % can signal that a stock is expensive relative to its fundamentals. Operating margin is the ratio of total operating income to net sales. View historical data on Axogen and its competitors. For the Medical Devices & Instruments industry, the median Operating Margin % is 3.41 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Axogen's current Operating Margin % is -4.61%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Axogen stock overvalued right now?
Based on GuruFocus' analysis, Axogen (LTS:0HKD) is currently considered Significantly Overvalued. The stock's GF Value™ is $14.95, compared to a current price of $44.13 — trading 195.2% above its estimated fair value. The current Operating Margin % is -4.61%. Axogen's overall GF Score™ is 62/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Operating Margin % calculated?
Operating Margin % is calculated from a company's financial statements. For Axogen (LTS:0HKD), the current Operating Margin % is -4.61% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Axogen (LTS:0HKD) Overvalued in 2026?

Based on GuruFocus' analysis, Axogen stock appears to be overvalued. The current stock price of $44.13 is trading 195.2% above its estimated GF Value™ of $14.95. GuruFocus considers Axogen to be Significantly Overvalued.

Key valuation signals for LTS:0HKD:

  • Operating Margin %: -4.61%
  • GF Value™: $14.95 vs. price of $44.13 (195.2% above fair value)
  • GF Score™: 62/100 with 4 warning signs

No single metric tells the full story. See the LTS:0HKD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Axogen Business Description

Other Exchanges AXGN:USALT3:Germany
Address 13631 Progress Boulevard, Suite 400, Alachua, FL, USA, 32615
Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company provides clinically and economically effective repair solutions for surgeons and health care providers. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap, and Avive Soft Tissue Membrane. It also offers an Axotouch Two-Point Discriminator used to measure the innervation density of any surface area of the skin. Its products are available in the United States, Canada, Germany, the United Kingdom, Spain, and several other countries.
62GF Score

Get the complete analysis for LTS:0HKD

Operating Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$44.13
Price
$14.95
GF Value